House of Commons photo

Crucial Fact

  • His favourite word was whether.

Last in Parliament March 2011, as Liberal MP for Eglinton—Lawrence (Ontario)

Lost his last election, in 2011, with 38% of the vote.

Statements in the House

Health March 9th, 1998

Mr. Speaker, the hon. member in a moment of rationality will acknowledge that the minister's initiatives in this regard are the only things going. The minister has already acted unilaterally. He has shown leadership. He has invited his colleagues at the provincial level to participate with him in a joint program. He has given them very clear indications and parameters. He has invited them to sit at the table, to negotiate properly and to ensure that this issue is put to rest once and for all for the sake of all who suffered this regrettable tragedy.

Privilege February 26th, 1998

Mr. Speaker, I regret anything I might have said that might have caused such vexation. Obviously anything I did say would have been in jest. If it offended the member, I withdraw it and I apologize.

Criminal Code February 17th, 1998

First of all, I have taken full note of the debate this evening. I followed it from the lobby and in the House. I am heartened by the fact that members on both sides of the House have such a keen interest in pursuing this issue.

The member for Drummond who sat on the committee in the last Parliament that dealt with C-47 has done a valuable service by reintroducing this bill in the House because it has begun to focus the attention of all members. In fact, she will know that the minister and the department were already focused on the issue again.

Taking a look at it and the principles associated both in her bill and with Bill C-47 which preceded it in the last Parliament, it is I think the intention of all members in the House, of course, with the minister and the department to ensure that the bill which did not make it through the entire legislative process in the last Parliament will be revisited again. This would take into consideration at the same time all the changes that have transpired in the interim.

While the member for Drummond introduces this as an amendment to the Criminal Code, she will of course acknowledge, as I think she has today and in the past, that this is a most important social and health issue.

It will be dealt with as an issue that pertains essentially to the health of Canadians everywhere, particularly as did Bill C-47 to women and children. They are much more the focus of Bill C-47.

I think the member has done a service to the House by ensuring that those of us who are new to the issue can come back, revisit it in its principles, its details and in its particulars. I am hoping that members will be as co-operative when the bill is reintroduced in the House as they have been tonight.

I thank all members for intervening in the debate.

Criminal Code February 17th, 1998

Madam Speaker, do I have more than two minutes left?

Hemp February 17th, 1998

Mr. Speaker, the member will know that several members on this side of the House approached the minister last year. They asked him to present regulations to govern the commercial growing of hemp. The minister met with these members and listened to them. Subsequently he ordered his department to move posthaste in developing regulations for such activity.

An interparliamentary committee was struck and presented draft regulations. I am pleased to advise the House that on December 27, 1997 these were published in The Canada Gazette . Since then there have been a series of meetings including—

Heart Awareness Month February 11th, 1998

Mr. Speaker, I am pleased to inform the House and all Canadians that February is Heart Awareness Month.

Cardiovascular disease remains Canada's leading cause of death and one of the major causes of disability. More than 79,000 Canadians die every year from heart disease and stroke. Besides the human toll of the disease, the cost to the economy is considerable: about $20 billion per year and more than 6.5 million days of hospitalization.

Cardiovascular disease is an area where we are making major health gains. The roots of heart disease and stroke are in the way we live. By eradicating smoking, promoting a healthy diet and physical activity we can help Canadians in preventing and

or postponing the onset of this disease.

Health Canada is proud to be collaborating with the Heart and Stroke Foundation of Canada and with all provincial health departments in the Canadian heart health initiative.

By investing in cardiovascular health, we can considerably reduce—

Medical Research Council February 5th, 1998

Mr. Speaker, I am sure that the hon. member has followed the pattern of funding through the MRC. He will acknowledge that there was $238 million invested through the MRC and an additional amount with the MRC partnerships that have been encouraged over the course of the last four years.

He will know that even in Saskatchewan, some of those partnerships include institutions, industry and other organizations in order to top up the amount of money that goes into basic research which he knows and appreciates that this government supports wholeheartedly.

Toy Labelling December 4th, 1997

Mr. Speaker, the House is being asked today to support a motion requiring toy manufacturers to label toys containing phthalates. It is claimed that such a measure would enable parents to make an informed decision when they buy toys for their children.

While the motion clearly seeks to protect children against potentially dangerous phthalates, it is not the best solution to the problem. Why? Because merely indicating on a label that a toy contains phthalates does not tell parents anything about the potential risk and is therefore of little help in making an informed decision.

The label can only be of some use if it specifies the type of phthalate, its concentration in the toy, and the concentrations which could potentially be harmful to a child. Moreover, if a particular toy was found to contain potentially dangerous phthalates, even in high enough concentrations to be harmful to children, it would not be necessary to issue a warning on the label, since that toy would simply not be sold. Indeed, the government would already have taken steps to have such a product taken off the market.

The second problem concerning the motion is the legislation. Should the motion be adopted, the Hazardous Products (Toys) Regulations under the Hazardous Products Act would have to be amended to make it compulsory to indicate the presence of phthalates in toys made with PVC plastic.

Again, this would be an unnecessary measure. As it now stands, the Hazardous Products Act already gives the government effective and powerful instruments to deal with potential threats to children's health. The act formally prohibits certain toxic solvents and substances. If it was found that some toys contain unacceptable levels of potentially harmful substances, the government would take appropriate measures to have these toys taken off the market.

I would like, if I may, to draw attention to an apparent oversight in this motion. The mere presence of phthalates in a given product does not necessarily constitute a health hazard. Health Canada officials are now looking at studies in order to determine whether the phthalates in question are in fact hazardous.

Finally, I would like to draw attention to the third problem with this motion, which is that the labelling it proposes for the products in question would not constitute a reliable or effective method in the event of an actual hazard. Labelling cannot take the place of energetic and decisive action, should such action ever be necessary.

In closing, I wish to stress that the Hazardous Products Act, together with Health Canada's ongoing monitoring, analysis and evaluation activities, provides the government with all the tools it needs to deal with any potential health hazard caused by the presence of phthalates in plastic PVC products.

In the motion, the hon. member asserts that the government should enact legislation mandating toy manufacturers to label toys containing phthalates in order to allow parents to make an informed decision when buying products for their children. The motion is well intentioned, but the fact is that there is no conclusive evidence linking all, and I stress the word all, phthalates in toys to health risks for children. In fact there has never been a reported case of a child experiencing ill effects from phthalates in this country or anywhere else. For this reason, it is difficult for us to support the motion at this time.

This does not mean however that the government is taking the matter lightly. Quite the contrary. As I indicated a moment ago, officials within the department are currently investigating the potential health risks of phthalates in polyvinyl chloride or PVC plastic toys. In other words, we are being proactive rather than reactive.

My minister, the minister responsible for the health and well-being of Canadian children, has already assured this House, and I repeat that assurance, that if at any time clear evidence of health risks from phthalates are established, appropriate action will be taken to protect the health of children and I dare say with alacrity.

Health Canada's investigation of potential health risks from phthalates includes ongoing information exchange with the department's counterparts in the United States and in Europe, with industry, advocacy groups and health associations, as well as a comprehensive literature assessment on the potential toxicity of phthalates.

As part of this investigation, Health Canada officials are undertaking a scientific risk assessment on phthalates in various PVC plastic products. This risk assessment involves two key elements: an evaluation to determine the presence of potentially toxic substances, and testing to see if these substances can in fact be absorbed by children.

I am confident that Health Canada's sound research combined with ongoing dialogue and consultation with government, industry and NGOs, stakeholders and players will result in a clear assessment of this issue, an assessment I am confident that will form a solid, well-informed basis for any possible future action on this matter by the Government of Canada. This approach focuses on solid evidence-based risk assessment as a means of understanding and acting on complex health issues, particularly as they relate to children.

Permit me to suggest that the thorough and comprehensive nature of our response to this potential health threat is also a reflection of the government's ongoing commitment to ensuring the health and safety of all of Canada's children.

Under the circumstances while it is well intentioned, the motion goes beyond what is already in place. In fact it becomes unnecessary. We have all the mechanisms already in place. They are already being utilized and they are being employed in a proactive and aggressive fashion.

Aids December 1st, 1997

Mr. Speaker, the commitment that was made has already been lived up to. As I indicated earlier, Canada is essentially a world leader in financing research to combat the AIDS epidemic and in providing funds for palliative care, for therapeutic care and for drug research.

That record is being replicated and improved upon with today's announcement of $211 million spread out over five years. That is in addition to all the funds that are being disbursed by other agencies like the Medical Research Council for that purpose.

Hiv-Aids December 1st, 1997

Mr. Speaker, the hon. member will know that in the course of the last mandate the amount of funds contributed to strategies to combat AIDS ranks second worldwide.

The $200 million plus that were designated for dealing with this epidemic have again been renewed for an additional five year term. It comes out to about $42.2 million per annum to address the epidemic, the therapies, the vaccines and perhaps a cure, hopefully a cure. Canada is leading and is in the forefront of addressing the AIDS epidemic.